Predict your next investment

Corporation
oxyscorp.com

See what CB Insights has to offer

About IIOT-OXYS

IIOT-OXYS uses a variety of sensors to capture and analyze massive amounts of data using machine learning and proprietary algorithms to identify discreet patterns and anomalies which can be associated to specific real world events and used to provide insights for the Med/Pharma, Manufacturing, Agriculture, Defense, and Structural Health, and other industries.

IIOT-OXYS Headquarter Location

705 Cambridge Street

Cambridge, Massachusetts, 02141,

United States

617-500-5101

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest IIOT-OXYS News

IIOT-OXYS, Inc. Provides SEC Form 10-Q Filing Update

Jul 7, 2020

Provides SEC Form 10-Q Filing Update CAMBRIDGE, MA / ACCESSWIRE / July 6, 2020 / IIOT-OXYS, Inc. (OTC PINK:ITOX) announced an update on their Quarterly Report on Form 10-Q filing for the period ended March 31, 2020. Cliff Emmons, CEO of IIOT-OXYS, Inc. stated, “IIOT-OXYS, Inc. is committed to keeping its shareholders well informed on the company’s SEC filings, specifically the filing of the Quarterly Report on Form 10-Q for the period ended March 31, 2020.” Due to circumstances stemming from the COVID-19 pandemic, IIOT-OXYS, Inc.’s leadership, legal, accounting, and audit teams determined that the Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2020 would be delayed beyond the current deadline of July 6, 2020. Mr. Emmons stated, “Our team has targeted late July to file, and is doing everything it can to file as early as possible.” Forward-Looking Statements This news release contains forward-looking statements that reflect Management’s current views about future events and financial performance. Forward-looking statements often contain words such as ”expects,” ”anticipates,” ”intends,” or ”believes.” Our forward-looking statements are subject to a number of risks and uncertainties that may cause actual results and events to differ materially from those projected in the forward-looking statements. Risks and uncertainties that could adversely affect us include, without limitation, the loss of major customers, our failure to obtain new contracts, our inability to patent products or processes, our infringement of patents held by others, our inability to finance our business and the other risks and uncertainties that are discussed in our most recent filings with the Securities and Exchange Commission. The forward-looking statements in this news release are made only as of the date of this news release. We undertake no obligation to update our forward-looking statements, whether as a result of new information, future events or otherwise. About Us IIOT-OXYS, Inc. is a technology company at the intersection of IIoT, AI & Machine Learning, Edge Computing and Manufacturing Operations. We provide actionable mission-critical insights for the Medical/Pharmaceutical, Manufacturing, Agriculture, Defense, and Structural Health, and other industries. IIOT-OXYS, Inc. edge computing open-source hardware and proprietary ML algorithms employ our Minimally-Invasive Load Monitoring (MILM) technology to simply gather data and gain insights to monitor, scope, move from preventive to predictive maintenance, and even optimize development and manufacturing processes. For additional information visit www.oxyscorp.com CONTACT:

IIOT-OXYS Acquisitions

1 Acquisition

IIOT-OXYS acquired 1 company. Their latest acquisition was Infinite Automation Systems on September 26, 2019.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

9/26/2019

Acquired

2

Date

9/26/2019

Investment Stage

Companies

Valuation

Total Funding

Note

Acquired

Sources

2

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.